Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Leflunomide

U.S. FDA Requirements: Leflunomide

Pharmaceutical / Drug Definition : Inhibits T-cell pyrimidine biosynthesis, tyrosine kinases, and dihydroorotate dehydrogenase, blocking structural damage caused by inflammatory response to autoimmune process. Also shows analgesic, antipyretic, and histamine-blocking activity.

Registrar Corp assists Leflunomide companies with:

  • FDA Registration Leflunomide
  • FDA Listing Leflunomide
  • FDA Label Requirements and Exceptions Leflunomide
  • FDA Import Information Leflunomide
  • FDA Detentions Leflunomide (Leflunomide Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Leflunomide (Leflunomide Suppliers)
       - Processors Leflunomide
       - Repackers Leflunomide
       - Relabelers Leflunomide
       - Exporters Leflunomide
       - Importers Leflunomide
For more information about Leflunomide, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco